Related Experiment Video

Updated: Jul 14, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers

Kyoichi Kaira1, Noriaki Sunaga, Yoshio Tomizawa

  • 1Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.

International Journal of Oncology
|June 6, 2007
PubMed

Insights

RAS association domain family 1B (RASSF2) gene silencing via promoter hypermethylation is frequent in lung cancers, particularly in non-smokers. This epigenetic alteration is linked to RASSF2 loss, suggesting its role in lung cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • RAS association domain family 1B (RASSF2) is a candidate tumor suppressor gene.
  • RASSF2 is frequently silenced by promoter hypermethylation in various human cancers.
  • Understanding RASSF2's role in lung cancer pathogenesis is crucial.

Purpose of the Study:

  • To investigate RASSF2 mRNA expression and promoter methylation status in lung cancer.
  • To determine the association between RASSF2 methylation and lung cancer characteristics.
  • To explore the potential of RASSF2 re-expression in lung cancer cell lines.

Main Methods:

  • Methylation-specific PCR was used to analyze RASSF2 promoter methylation.
  • RASSF2 mRNA expression levels were quantified.
  • Lung cancer cell lines and 106 primary non-small cell lung cancer (NSCLC) tumor samples were analyzed.
  • Drug treatments (5-aza-2-deoxycytidine and/or trichostatin-A) were employed to assess RASSF2 re-expression.

Main Results:

  • RASSF2 expression was lost in 26% of small cell lung cancers (SCLCs) and 50% of non-small cell lung cancers (NSCLCs).
  • RASSF2 promoter methylation was detected in 18% of SCLC cell lines and 62% of NSCLC cell lines, correlating with RASSF2 expression loss.
  • RASSF2 methylation occurred in 31% of primary NSCLC tumors and was significantly more frequent in non-smokers (45%) than smokers (23%).
  • RASSF2 expression was restored in NSCLC cell lines upon treatment with demethylating agents.

Conclusions:

  • Aberrant methylation of the RASSF2 gene and subsequent loss of expression play a significant role in lung cancer pathogenesis.
  • RASSF2 promoter hypermethylation is a key epigenetic event in lung cancer development.
  • RASSF2 methylation status may serve as a potential biomarker, particularly in non-smoker lung cancer patients.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...